Clinical Trial Update: High-Flow-Therapy for the Treatment of Cheyne-Stokes-Respiration in Chronic Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial updating the use of high-flow therapy for Cheyne-Stokes respiration in chronic heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Heart and Diabetes Center North-Rhine Westfalia | Conditions: Heart Failure，Congestive | Phase 3 | Status: TERMINATED